conivaptan has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, K; Der-Nigoghossian, C; Lesch, C | 1 |
| Kahle, KT; Simard, JM; Walcott, BP | 1 |
1 review(s) available for conivaptan and Nervous System Disorders
| Article | Year |
|---|---|
Novel treatment targets for cerebral edema.
Topics: Antidiuretic Hormone Receptor Antagonists; ATP-Binding Cassette Transporters; Benzazepines; Brain Edema; Bumetanide; Cerebral Cortex; Humans; Nervous System Diseases; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Sulfonylurea Receptors | 2012 |
1 other study(ies) available for conivaptan and Nervous System Disorders
| Article | Year |
|---|---|
Effectiveness and Tolerability of Conivaptan and Tolvaptan for the Treatment of Hyponatremia in Neurocritically Ill Patients.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cohort Studies; Critical Illness; Female; Humans; Hypokalemia; Hyponatremia; Injections, Intravenous; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Sodium; Tolvaptan; Treatment Outcome | 2017 |